|
|
|
Adoption, 43 |
Anomalies, congenital see Congenital malformations |
Antenatal care, standards, 15–16 |
Apgar scores, 39 |
Audit of standards of care, 3, 4 |
|
Women with pre-gestational diabetes, 1, 2 |
|
Babies |
|
Condition at birth, 39 |
|
Description, 37–40 |
|
Feeding, 44–45 |
|
|
difficulties, 43 |
|
|
management, 46 |
|
|
timing, 44–45 |
|
Gestation, 37–38 |
|
Sex, 37 |
|
Special care, 44 |
|
Standards of care, 42–48 |
|
Term, 43 |
Birth trauma, 37, 38–39, 53 |
Birth weight, 38, 53 |
Blood glucose testing, 17, 23–25, 46–48 |
|
Methods, 47 |
Brachial plexus injury, 39 |
Breastfeeding, 45–46, 54 |
British Paediatric Surveillance Unit, 39 |
Bruising, 39 |
|
Caesarean section, 18, 30, 39, 53 |
|
Emergency, 30, 39 |
|
Indications, 28–29 |
|
Preterm, 31, 53 |
Clinics |
|
Multidisciplinary, 2 |
Confidential Enquiry into Maternal and Child Health (CEMACH), 1 |
|
Diabetes programme of care, 2, 35 |
Congenital malformations, 1, 2, 3, 15, 32–33, 34, 50 |
|
Groupings, 66 |
|
Minor anomalies, 67 |
|
Rate, 1 |
Corticosteroids, 16–17 |
Cyanotic episodes, 43 |
|
Data collection, 2 |
|
Limitations, 4 |
Delivery |
|
Characteristics, 27–31 |
|
Facilities at, 42 |
|
Mode, 18, 28 |
|
Preterm, 29–30 |
|
Standards of care, 18–20 |
|
Timing, 18 |
Deprivation score, 11 |
Dextrose, intravenous, 19 |
Diabetes Education and Self-Management for Ongoing and Newly Diagnosed (DESMOND), 52 |
Diabetes multidisciplinary resource group, 4 |
Dose Adjustment for Normal Eating (DAFNE), 52 |
|
Erb's palsy, 39, 40, 53 |
Ethnic minority groups, 1, 11, 12–13, 50 |
European Surveillance of Congenital Anomalies (EUROCAT), 3, 33, 34 |
|
Fetal blood sampling, 19 |
Fetal losses, 3 |
Folic acid supplementation, 15, 34, 50, 51–52 |
Fractures, 39 |
Free-text information, 4 |
|
Glucagon kit, 17–18 |
Glycosated haemoglobin (HbA1c) measurement, 17, 22, 52–53 |
Glycaemic control, 17–18, 22–26, 50, 52–53 |
|
Tests, 23–24 |
|
Values, 24–25 |
|
Haemocue®, 47 |
Health and Social Care Act, 3 |
High-dependency care, 43 |
Hyperinsulinism, 46 |
Hypoglycaemia, 34, 37, 38, 43, 44, 45, 46, 47 |
Hypoglycaemic episodes, 4 |
|
Immune system, 1 |
Index of Multiple Deprivation (IMD) score, 11 |
Infant feeding, 44–45 |
|
Difficulties, 43 |
|
Management, 46 |
|
Timing, 44–45 |
Infants see Babies |
Information leaflets, 2 |
Insulin, 1 |
|
Intravenous, 19 |
|
Resistance, 1 |
Intensive care, 43 |
International Classification of Diseases (ICD), 3, 66 |
Intrapartum fetal heart monitoring, 19 |
Ischaemic heart disease, 13 |
|
Jaundice, 44 |
|
Labour |
|
Characteristics, 27–31 |
|
Induction, 27–28, 30 |
|
Onset, 27 |
|
Standards of care, 18–20 |
|
Macrosomia, 37, 38 |
Maternal deaths, 13 |
Maternity services, 1 |
Melanoma, malignant, 13 |
Mitral valve replacement, 13 |
|
National Service Framework (NSF) for Diabetes, 4, 27, 54 |
Neonatal |
|
Care, 43, 54 |
|
Complications, 53–54 |
|
Death, 32, 37 |
|
|
definition, 3 |
Neonatal mortality rate, 1, 2 |
Neonatal unit |
|
Admission, 40, 42, 44 |
|
Routine admission, 43–44, 54 |
Neural tube defects, 15, 52 |
|
Pancreas, 1 |
PBS Diabetes Population Prevalence Model, 6 |
Perinatal death, definition, 3 |
Perinatal mortality rate, 1, 2, 3, 32, 33–34, 35, 50 |
Preconception care, 14–15, 20, 51–52 |
Pre-eclampsia, 30 |
Pre-gestational diabetes, 1 |
Pregnancy |
|
Care during, 20 |
|
Diabetes in, prevalence, 6–8, 51 |
|
Loss |
|
Outcomes, 1, 32–35 |
|
Terminations, 3, 51 |
Prematurity, 37, 43 |
Pre-pregnancy |
|
Care, 2 |
|
Counselling, 50 |
Preterm delivery, 20–30, 31, 53 |
Pulmonary embolism, 13 |
|
Reagent strips, 47 |
Renal function, 4 |
Respiratory distress, 34, 37, 43 |
Retinal assessment, 18 |
Rupture, uterine, 30 |
|
St Vincent Declaration, 1, 26, 50, 53, 54 |
Scottish Intercollegiate Guidelines Network (SIGN), 4 |
Separation of mother and baby, 42–43 |
Sepsis, 13, 43 |
Shoulder dystocia, 30, 37, 38–39, 40, 53 |
Special care, babies, 44 |
Standards of care |
|
Babies, 42–48, 68–69 |
|
Mother, 14–20, 68–69 |
Steroid therapy, 16–17 |
Super output area, 11 |
Stillbirth, 53 |
|
Definition, 3 |
|
Rate, 2 |
|
Transitional care nursery, 54 |
Trauma, birth, 37, 38–39, 53 |
Triplets, 32 |
Twins, 32 |
Type 2 diabetes, 11, 50 |
|
Prevalence in pregnancy, 51, 54 |
|
Ultrasound scan |
|
First-trimester dating, 15–16 |
Uterine rupture, 30 |
|
Vaginal delivery, 31 |
|
Assisted, 39 |
|
Spontaneous, 18 |
|
Women with diabetes |
|
Characteristics, 10–11 |
|
|